David Webb, Ph.D.

Adjunct Professor, Department of Molecular Biology
The Scripps Research Institute

Upon his retirement from Celgene-San Diego in June 2011, Dr. Webb became Adjunct Professor, Department of Molecular Biology at The Scripps Research Institute. He is associated with the laboratory of Professor Ray Stevens, which studies the structural biology and pharmacology of G-protein coupled receptors with a focus on receptors that have therapeutic potential. He is currently Chairman of the Board of BIOCOM, a member of the Executive Committee of the Board of CONNECT and a member of the Board of Directors of the La Jolla Institute of Allergy and Immunology.

Dr. Webb joined Celgene-San Diego in September, 2003 as Vice President, Research. During this time, the Research Division placed six drugs into clinical development; four of which are still in clinical studies (Phases I and II) in the areas of cancer and inflammation/autoimmunity (one with Array Biopharma). Between 1995 and 2003, he held a series of senior management positions in several biotechnology companies where he developed and led drug discovery programs focused on inflammation, asthma, cancer and diabetes. These included Syrrx which he joined in 2001 as Vice President of Drug Discovery and led a team that discovered and developed alogliptin for type II diabetes; OSI Pharmaceuticals (Corporate Vice President, Drug Discovery 1999-2001) where he was associated with the development of Tarceva; and Cadus Pharmaceutical Corporation where he was Vice President of Research and Chief Scientific Officer at from 1995 to 1999 and adjunct professor of Microbiology and Immunology at New York Medical College. From 1987 to 1995, Dr. Webb was at Syntex, Inc where he held the positions of Distinguished Scientist and later, Director, Institute of Immunology and Biological Sciences where he was part of the development team for CelCept, and was a Consulting Professor of Cancer Biology at Stanford University. From 1973-1987 he was a member of the Department of Cell Biology, Roche Institute of Molecular Biology and Adjunct Associate Professor at Columbia University, College of Physicians and Surgeons. From 1971-73 he was a Dernham Junior Fellow of the American Cancer Society, California Division at UCSF. He has published over 200 abstracts and papers and has been a member of numerous editorial boards and study sections in Immunology.